Lodoxamidetromethamine
CAS : 63610-09-3
Ref. 3D-FL151513
2mg | Arrêté | ||
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté |
Informations sur le produit
- 1,3-Propanediol, 2-amino-2-(hydroxymethyl)-, 2,2′-[(2-chloro-5-cyano-1,3-phenylene)diimino]bis[2-oxoacetate] (2:1) (salt)
- 2,2'-((2-Chloro-5-cyano-1,3-phenylene)diimino)bis(2-oxoacetic acid), compd. with 2-amino-2- (hydroxymethyl)-1,3-propanediol (1:2)
- 2,2'-[(2-Chloro-5-Cyanobenzene-1,3-Diyl)Diimino]Bis(Oxoacetic Acid) - 2-Amino-2-(Hydroxymethyl)Propane-1,3-Diol (1:1)
- Acetic acid, 2,2'-((2-chloro-5-cyano-1,3-phenylene)diimino)bis(2-oxo-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:2)
- Acetic acid, 2,2′-[(2-chloro-5-cyano-1,3-phenylene)diimino]bis[2-oxo-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:2)
- Almide
- Alomide
- Lodoxamide trometamol
- Lodoxamide tromethamine [USAN]
- Lodoxamide tromethamine salt
- Voir d'autres synonymes
- N,N'-(2-Chloro-5-cyano-m-phenylene)dioxamic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:2)
- U 42,585E
- Unii-50Lv9A548L
Lodoxamide tromethamine is a carbonyl compound that was originally used in the treatment of eye disorders. Lodoxamide tromethamine has been shown to inhibit the release of histamine, thereby reducing allergic reactions. This drug also inhibits the activity of adenosine receptor subtypes, which are ligand-gated ion channels that modulate neurotransmission and smooth muscle contraction. Lodoxamide tromethamine has been shown to be effective in treating microbial infections in wild-type mice, but not in creatine kinase knockout (CK-/-) mice. It also has anti-inflammatory effects and can reduce camp levels, which may cause respiratory distress.